Welcome, NCI Experimental Therapeutics Platform Dr. John Niederhuber, Director, NCI |
|
|
NExT and CBC Programs Dr. James Doroshow, Director, DCTD |
|
|
Unique Resources in CCR Dr. L. Michelle Bennett, Deputy Director, CCR |
|
|
Discovery and Development of Indenoisoquinolines Dr. Yves Pommier, Chief, LMP, CCR |
|
|
The NIH Chemical Genomics Center: Therapeutic Development through Advances in Chemical Biology Dr. Christopher Austin, NCGC |
|
|
Reaching for High Hanging Fruit in Drug Discovery Speaker A: Dr. Michelle Arkin, UCSF Speaker B: Dr. James Wells, UCSF |
|
|
Targets by Burnham Dr. Kristiina Vuori, Burnham Institute for Medical Research |
|
|
Exploiting Novel Targets in Solid Tumor Microenvironments for Cancer Therapy Dr. Lidia Sambucetti, SRI |
|
|
Discovery and Development of Potent Inhibitors of the Wnt Signaling Pathway Dr. Alex Waterson, Vanderbilt Institute of Chemical Biology |
|
|
The University of Pittsburg Chemical Discoveries Center: Using Chemistry to Discover Novel Cancer Therapeutics Dr. Donna Huryn, University of Pittsburgh |
|
|
Identifying Small Molecule Inhibitors of Cancer Relevant Targets at the UPDDI Dr. John S. Lazo, University of Pittsburgh Drug Discover Institute |
|
|
North Carolina Comprehensive Chemical Biology Screening Center: Introduction and Target Preview Dr. Stephen Frye, UNC |
|
|
CBC Minnesota Drug Discovery and Development Projects and Resources Dr. Gunda L. Georg, University of Minnesota |
|
|
Georgetown University Medical Center Drug Discovery Program Dr. Milton Brown, Georgetown University |
|
|
Emory Chemical Biology Discovery Center: Targeting Protein Interactions for Anticancer Agent Discovery Dr. Haian Fu, Emory University |
|
|
Examples of Internal Southern Research Institute Programs that Demonstrate the Breadth of Our Abilities to Contribute to the CBC Program Dr. W. Blaine Knight, Southern Research Institute |
|
|